Granules India update on USFDA audit of facility in Chantilly, Virginia, USA

Capital Market 

Gets one observation on completion of inspection

announced that Granules Pharmaceuticals Inc, facility, a wholly owned foreign subsidiary of the Company located in Chantilly, Virginia, completed its first audit from 04 December 2017 to 08 December 2017 by USFDA with one observation.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, December 11 2017. 11:10 IST